Immvira
Shenzhen
About Immvira
Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $98.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2022)
- Website: immvira-theravir.com
- Phone: (0755)28291816
Industries & Categories
Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/immvira-29820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.